Topical ketoprofen: reminder on risk of photosensitivity reactions

European Medicines Agency says further measures should be put in place to minimise the risk of adverse skin reactions.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 11 December 2014

• Therapeutic area: Pain management and palliation

Article date: August 2010

Healthcare professionals are reminded of the risk of photosensitivity reactions associated with topical ketoprofen.

The European Medicines Agency Committee for Medicinal Products for Human Use has recently completed a review of the medicine바카라 사이트檚 safety and efficacy, and has concluded that further measures should be put in place to minimise the risk of adverse skin reactions.

Further information can be found on the .

Advice for healthcare professionals:

• patients should ensure that treated areas are protected from sunlight during the whole period of topical ketoprofen treatment and for 2 weeks after stopping treatment; they should also carefully wash their hands after every application
• patients should stop treatment immediately if they develop any skin reaction after application of these medicines and seek their doctor바카라 사이트檚 advice
• patients should be informed of the appropriate use of topical ketoprofen as outlined in the product information

See also .

Article citation: Drug Safety Update Aug 2010, vol聽4 issue 1: S3.

Published 11 December 2014